Evidence map›Paper›PMID 23960897›Full record

ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society2011

Medical management of thyroid eye disease.

Dawn D Yang, Mithra O Gonzalez, Vikram D Durairaj

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Tocilizumab for thyroid eye disease.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Article
  3. Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Update in oculoplastic imaging.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society · 2012
    Article
  8. Thyroid associated orbitopathy: Understanding pathophysiology.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dawn D YangUniversity of Colorado Denver School of Medicine, Department of Ophthalmology, Division of Oculofacial Plastic and Reconstructive Surgery, United States.
Mithra O Gonzalez
Vikram D Durairaj
University of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid eye disease (TED) is the most common cause of orbital disease in adults. The immunologic pathogenesis of TED has been an area of active research and considerable progress has resulted in an expansion of therapeutic options. Although surgical intervention may be required, a majority of TED patients can be managed with medical therapies. Of medical therapies, glucocorticoids remain the agent of choice in the control of TED activity. The objective of this review is to discuss the paradigm and options in medical management of TED.

Indexed as

ExophthalmosEyelid retractionGraves’ ophthalmopathyThyroid-associated ophthalmopathyThyroid eye disease

Identifiers

PMID23960897
PMCPMC3729509
OpenAlexW2039326633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.